Stock Trading Canary

United States · SEC Form 4 · Snapshot date: 2026-10-19 · Built: 2026-10-19 · 中文

← United States · Coverage record

US · SEC FORM 4

Immunome Inc.

IMNM · Nasdaq · CIK 0001472012 · Healthcare · Biotechnology

INSIDER SIGNAL

No active buy signal

2 qualifying P purchase groups
in the current 180-day scoring window

40 Form 4 transaction lines observed in the same window
21 sales · 15 option, withholding, award, gift or other lines

Last qualifying purchase2026-06-05 · BIENAIME JEAN JACQUES · $204.3K

WHY NO ACTIVE SIGNAL?

Purchase activityPresent
Recent buying2 qualifying line group(s)
Recent salesHigh
Buy signal statusInactive
Score anatomy

No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.

ClusterNot calculated
Purchase sizeNot calculated
RoleNot calculated
RecencyNot calculated
ConvictionNot calculated

Why is there no score?

  • No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
  • Sales and other Form 4 activity remain visible as context and do not create a negative score.

Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.

Purchase breadth & concentration

QUALIFYING BUYERS1
PURCHASE CONCENTRATION100%Largest buyer: BIENAIME JEAN JACQUES · $307.8K
CLUSTER BUYING · 15D1 insiderPeak activity: 2026-05-15–2026-05-15

Roles in the peak window: Director. Concentration uses priced qualifying P lines only and does not change the saved score.

Insider activity timeline

Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.

AprMayJunJulAugSepOct
Barchas IsaacDirector
▼▼▼▼▼▼▼▼▼
Horn KinneyCHIEF BUSINESS OFFICER
○▼○○▼
Lechleider RobertChief Medical Officer
○▼○▼○
Higgins JackChief Scientific Officer
○○○▼
Rosett MaxChief Financial Officer
○▼○
BIENAIME JEAN JACQUESDirector
●●▼
● Purchase▼ Sale○ Other

Showing the six most active owners; 3 additional owner(s) remain in Form 4 evidence.

SIGNAL HISTORY

No recorded active-signal snapshot

Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2026-06-05 · BIENAIME JEAN JACQUES.

Recent Form 4 activity

11Purchases
28Sales
19Other Form 4 lines
30SEC filings · 365 days
BUYING4 qualifying P line(s) · 180 days
SELLING21 sale line(s) · context only
OTHER15 exercise / withholding / award / gift / other lines
10b5-1 / PLANNEDNot assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

Market context

Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.

Short interest

Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.

Shares short
16,757,287
Previous report
16,244,557
Avg daily volume
1,691,367
Days to cover
9.9

FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.

Historical equity purchases

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting ownerTypeSecuritySharesAvg. priceApprox. valueSource
2026-06-05BIENAIME JEAN JACQUESPurchase (P)Common Stock10,500USD 19.45USD 204,260SEC filing ↗
2026-05-15BIENAIME JEAN JACQUESPurchase (P)Common Stock5,000USD 20.70USD 103,500SEC filing ↗
2026-03-27SIEGALL CLAY BPurchase (P)Common Stock25,450USD 19.67USD 500,602SEC filing ↗
2026-03-11BIENAIME JEAN JACQUESPurchase (P)Common Stock1,000USD 21.55USD 21,550SEC filing ↗
2026-03-10BIENAIME JEAN JACQUESPurchase (P)Common Stock1,000USD 22.12USD 22,120SEC filing ↗
2025-12-30SIEGALL CLAY BPurchase (P)Common Stock4,729USD 21.15USD 100,018SEC filing ↗
2025-12-19Tsai PhilipPurchase (P)Common Stock10,000USD 20.49USD 204,900SEC filing ↗
2025-12-19SIEGALL CLAY BPurchase (P)Common Stock7,278USD 20.48USD 149,053SEC filing ↗
2025-12-18SIEGALL CLAY BPurchase (P)Common Stock46,511USD 21.50USD 999,986SEC filing ↗
2025-06-03BIENAIME JEAN JACQUESPurchase (P)Common Stock5,000USD 9.38USD 46,900SEC filing ↗
2025-03-26SIEGALL CLAY BPurchase (P)Common Stock137,100USD 7.29USD 999,459SEC filing ↗
2025-03-25BIENAIME JEAN JACQUESPurchase (P)Common Stock7,800USD 7.78USD 60,684SEC filing ↗
2025-03-24Tsai PhilipPurchase (P)Common Stock12,300USD 8.42USD 103,566SEC filing ↗
2025-03-24BIENAIME JEAN JACQUESPurchase (P)Common Stock7,000USD 8.21USD 57,470SEC filing ↗
2025-01-31SIEGALL CLAY BPurchase (P)Common Stock150,000USD 7.75USD 1,162,500SEC filing ↗

Form 4 evidence

58 transaction lines in the latest 365-day window; 109 in local history.

DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-09-11Higgins JackSale (S)Common Stock13,200USD 25.32USD 334,224SEC filing ↗
2026-09-11Higgins JackOption exercise / conversion (M)Common Stock18,000USD 1.35USD 24,300SEC filing ↗
2026-09-11Higgins JackGift (G)Common Stock8,800USD 0.00USD 0SEC filing ↗
Show recent Form 4 evidence (30 grouped rows)
DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-09-11Higgins JackSale (S)Common Stock13,200USD 25.32USD 334,224SEC filing ↗
2026-09-11Higgins JackOption exercise / conversion (M)Common Stock18,000USD 1.35USD 24,300SEC filing ↗
2026-09-11Higgins JackGift (G)Common Stock8,800USD 0.00USD 0SEC filing ↗
2026-08-12Barchas IsaacSale (S)Common Stock11,048USD 27.25USD 301,058SEC filing ↗
2026-08-11Barchas IsaacSale (S)Common Stock62,291USD 26.23USD 1,633,893SEC filing ↗
2026-08-10Barchas IsaacSale (S)Common Stock10,125USD 26.07USD 263,959SEC filing ↗
2026-08-07Barchas IsaacSale (S)Common Stock15,248USD 26.06USD 397,363SEC filing ↗
2026-08-06Barchas IsaacSale (S)Common Stock20,840USD 26.06USD 543,090SEC filing ↗
2026-08-04Horn KinneySale (S)Common Stock90,616USD 25.09USD 2,273,555SEC filing ↗
2026-08-04Horn KinneyOption exercise / conversion (M)Common Stock90,616USD 11.89USD 1,077,379SEC filing ↗
2026-07-23Tsai PhilipAward / grant (A)Common Stock38,250USD 0.00USD 0SEC filing ↗
2026-07-23Stoneman Sandra G.Award / grant (A)Common Stock38,250USD 0.00USD 0SEC filing ↗
2026-07-23SIEGALL CLAY BAward / grant (A)Common Stock180,000USD 0.00USD 0SEC filing ↗
2026-07-23Rosett MaxAward / grant (A)Common Stock47,250USD 0.00USD 0SEC filing ↗
2026-07-23Lechleider RobertAward / grant (A)Common Stock54,000USD 0.00USD 0SEC filing ↗
2026-07-23Horn KinneyAward / grant (A)Common Stock31,250USD 0.00USD 0SEC filing ↗
2026-07-23Higgins JackAward / grant (A)Common Stock38,250USD 0.00USD 0SEC filing ↗
2026-07-07Horn KinneySale (S)Common Stock1,092USD 25.00USD 27,300SEC filing ↗
2026-07-07Horn KinneyOption exercise / conversion (M)Common Stock1,092USD 12.92USD 14,109SEC filing ↗
2026-07-07Barchas IsaacSale (S)Common Stock16,906USD 24.20USD 409,125SEC filing ↗
2026-07-06Barchas IsaacSale (S)Common Stock83,094USD 24.11USD 2,003,396SEC filing ↗
2026-07-02Lechleider RobertSale (S)Common Stock55,000USD 22.62USD 1,244,331SEC filing ↗
2026-07-02Lechleider RobertOption exercise / conversion (M)Common Stock55,000USD 8.73USD 480,150SEC filing ↗
2026-07-02Barchas IsaacSale (S)Common Stock100,000USD 22.59USD 2,258,848SEC filing ↗
2026-06-30Barchas IsaacSale (S)Common Stock101,050USD 21.12USD 2,134,176SEC filing ↗
2026-06-25Lechleider RobertSale (S)Common Stock55,000USD 19.85USD 1,091,662SEC filing ↗
2026-06-25Lechleider RobertOption exercise / conversion (M)Common Stock55,000USD 8.73USD 480,150SEC filing ↗
2026-06-15Rosett MaxSale (S)Common Stock60,000USD 18.23USD 1,093,800SEC filing ↗
2026-06-15Rosett MaxOption exercise / conversion (M)Common Stock60,000USD 1.05USD 63,000SEC filing ↗
2026-06-05BIENAIME JEAN JACQUESSale (S)Common Stock10,500USD 19.41USD 203,820SEC filing ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

Snapshot & identity

Snapshot date2026-10-19
Ranking versionUS-v1.2
Data qualityPASS ELIGIBLE · —
TickerIMNM
CIK0001472012
SectorHealthcare
IndustryBiotechnology Yahoo Finance
SEC SIC2834 Pharmaceutical Preparations
ExchangeNasdaq

Data coverage

Local Form 4 history109 transaction lines from 2020-10-06 to 2026-09-11
42 P purchase lines · 30 S sale lines · 37 other lines
SEC company submissionsOpen SEC filings ↗

Local ledger as of 2026-10-19. Mapping status is an audit field and does not erase SEC filing evidence.